Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
According to an annual Gallup poll that surveys approximately 10,000 U.S. adults, 7.2% of Americans aged 18 and older...
As we head into summer, enjoy this month’s selection of studies spotlighted by the editors of the 10 AACR...
Although not as common as breast, prostate, or lung cancer, kidney cancer is one of the most frequently diagnosed...
The milieu of cells, proteins, and vasculature that comprise the tumor microenvironment can hinder efforts to treat cancer. This...
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
A study that examined the catchment areas of 102 cancer centers in the U.S. found that while over a...
Editor’s note: As we honor National Cancer Survivor Month, we are also recognizing the AACR Scientist↔Survivor Program’s positive impact...